Skip to main content

Table 4 Parameter estimates (analogous to Table 2) for regression analyses adjusting for SGRQ score or FEV1

From: Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression

Parameter

Estimate

Implied percentage change

pB

Adjusting for SGRQ (28 studies):

 Rate intercept β0

0.760 (−1.301, 2.804)

  

 Rate slope β1 (publication year)

−0.096 (− 0.130, − 0.058)

−9.114 (− 12.205, − 5.644)

<  0.001

 Rate slope β2 (SGRQ score)

−0.001 (− 0.041, 0.038)

−0.093 (− 4.015, 3.923)

0.961

 Rate random effect σλ

0.247 (0.145, 0.415)

  

 Overdispersion mean μφ

0.263 (−0.645, 0.917)

  

 Overdispersion random effect σφ

0.954 (0.414, 1.723)

  

adjusting for FEV1 (50 studies):

 Rate intercept β0

1.674 (0.876, 2.482)

  

 Rate slope β1 (publication year)

−0.050 (−0.079, − 0.022)

−4.912 (− 7.598, − 2.172)

0.001

 Rate slope β2 (FEV1)

− 0.028 (− 0.046, − 0.011)

−2.810 (− 4.517, −1.093)

0.002

 Rate random effect σλ

0.374 (0.279, 0.498)

  

 Overdispersion mean μφ

− 0.150 (−1.008, 0.340)

  

 Overdispersion random effect σφ

0.726 (0.299, 1.508)

  

Adjusting for SGRQ and FEV1 (25 studies):

 Rate intercept β0

2.664 (−0.261, 5.583)

  

 Rate slope β1 (publication year)

−0.045 (− 0.102, 0.008)

−4.404 (−9.737, 0.816)

0.094

 Rate slope β2 (SGRQ score)

−0.009 (− 0.051, 0.035)

−0.849 (− 4.963, 3.610)

0.690

 Rate slope β3 (FEV1)

−0.042 (− 0.079, − 0.004)

−4.131 (− 7.614, − 0.369)

0.032

 Rate random effect σλ

0.269 (0.161, 0.426)

  

 Overdispersion mean μφ

0.123 (− 0.777, 0.777)

  

 Overdispersion random effect σφ

0.744 (0.273, 1.598)